MANNKIND CORP (MNKD:NASDAQ)
$4.09 -0.05 (-1.2077%)
Analysed MANNKIND CORP (MNKD:NASDAQ) News Sources
MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF
03-06-2026
yahoo.com
MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
05-06-2026
yahoo.com
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
05-06-2026
yahoo.com
Jim Cramer Says He Blessed MannKind as a Speculation Only
08-06-2026
yahoo.com
MannKind (MNKD) Stock And Valuation After New Afrezza And FUROSCIX Clinical Data
12-06-2026
yahoo.com
Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
13-06-2026
yahoo.com
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
23-06-2026
yahoo.com
Is MannKind Corporation (MNKD) A Good Stock To Buy Now?
29-06-2026
yahoo.com
MannKind (MNKD) Receives a Grant from Breakthrough T1D
03-07-2026
yahoo.com
MannKind Corporation (MNKD) Up 20% Since Afrezza FDA Approval
09-07-2026
yahoo.com
What is the current price of MANNKIND CORP (MNKD:NASDAQ)?
The current price of MANNKIND CORP (MNKD:NASDAQ) is $4.09.
MANNKIND CORP (MNKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is $-0.05.
MANNKIND CORP (MNKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is -1.2077%.
What is the most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ)?
The most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for MANNKIND CORP (MNKD:NASDAQ)?
The most recent sentiment for MANNKIND CORP (MNKD:NASDAQ) is .
SEC-8K** Filing Available For MANNKIND CORP (MNKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.